We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Evidence-based recommendations to protect first responders from exposure to fentanyl.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Product Safety Report for Teeth Whitening Kit presenting a serious chemical risk.
Product Safety Report for Spooky Season Eyeshadow Palette presenting a serious chemical risk.
Product Safety Report for Christmas Spirit Eyeshadow Palette presenting a serious chemical risk.
Use these forms and guidance document to export powdered collagen, collagen gel, casings or film to use in food or other human consumption to the People's Republic of China.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Newletters providing updates for the forensic community in support of the Fingermark Visualisation Manual since 2003.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Stalking victims have been urged to report offending swiftly and with confidence to prevent the risk of further harm during National Stalking Awareness Week.
Product Safety Report for ToysButty Slime Kits presenting a serious chemical risk.
Patient group direction (PGD) templates for post exposure prophylaxis and treatment of flu for adult residents and staff of care homes.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.